The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, S. B.
Right arrow Articles by Foxwell, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. B.
Right arrow Articles by Foxwell, B.

The Journal of Immunology, Vol 158, Issue 12 5596-5602, Copyright © 1997 by American Association of Immunologists


ARTICLES

Autocrine and paracrine regulation of human T cell IL-10 production

SB Cohen, SL Parry, M Feldmann and B Foxwell
Kennedy Institute of Rheumatology and The Anthony Nolan Bone Marrow Trust and the Department of Hematology, The Royal Free Hospital, London, United Kingdom. Shara@rfhsm.ac.uk

We confirm that IL-10 is produced comparatively late after the activation of human T cells via CD3 stimulation, after IL-2 and IFN- gamma. Furthermore we show that IL-10 production by human T cell lines, such as IFN-gamma and IL-2, is inhibited by the immunosuppressive drugs cyclosporin A and FK506. However, a third immunosuppressive drug, rapamycin, normally associated with inhibiting the effects, but not the production, of cytokines, inhibited IL-10, but not IFN-gamma, production. This implies that IL-10 induction may be a secondary event in T cell activation. Since IL-2 is the major growth factor for T cells and is detected before IL-10, we focused on this factor as a potential activator of IL-10 production. We showed that IL-10 production by human T cell lines stimulated by immobilized anti-CD3 in the presence of neutralizing Abs to IL-2 and IL-2R (anti-CD25) was inhibited, whereas addition of exogenous IL-2 enhanced IL-10 production, indicating that IL-10 production by human T cells can be driven by stimulation via IL- 2. As the IL-2R shares the common gamma-chain component with IL-4, IL- 7, and IL-15, we investigated the possibility that they may all enhance anti-CD3-induced IL-10 production and established that this was the case. Since IL-10 has been previously described as a direct inhibitor of Ag presentation and of IL-2 production, our finding that IL-2 is capable of inducing its own inhibitor demonstrates a feedback mechanism within the immune system that could limit ongoing T cell activation and possibly inflammation.


This article has been cited by other articles:


Home page
JCOHome page
E. Th. Petridou, T. N. Sergentanis, N. Dessypris, I. T. Vlachantoni, S. Tseleni-Balafouta, A. Pourtsidis, M. Moschovi, S. Polychronopoulou, F. Athanasiadou-Piperopoulou, M. Kalmanti, et al.
Serum Adiponectin As a Predictor of Childhood Non-Hodgkin's Lymphoma: A Nationwide Case-Control Study
J. Clin. Oncol., October 20, 2009; 27(30): 5049 - 5055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Halonen, I. C. Lohman, D. A. Stern, A. Spangenberg, D. Anderson, S. Mobley, K. Ciano, M. Peck, and A. L. Wright
Th1/Th2 Patterns and Balance in Cytokine Production in the Parents and Infants of a Large Birth Cohort
J. Immunol., March 1, 2009; 182(5): 3285 - 3293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. R. Nepomuceno, C. E. Balatoni, Y. Natkunam, A. L. Snow, S. M. Krams, and O. M. Martinez
Rapamycin Inhibits the Interleukin 10 Signal Transduction Pathway and the Growth of Epstein Barr Virus B-cell Lymphomas
Cancer Res., August 1, 2003; 63(15): 4472 - 4480.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. L. Komisar, C.-F. Weng, A. Oyejide, R. E. Hunt, C. Briscoe, and J. Tseng
Cellular and Cytokine Responses in the Circulation and Tissue Reactions in the Lung of Rhesus Monkeys (Macaca mulatta) Pretreated with Cyclosporin A and Challenged with Staphylococcal Enterotoxin B
Toxicol Pathol, April 1, 2001; 29(3): 369 - 378.
[Abstract] [PDF]


Home page
JEMHome page
L. Girgis, M. M. Davis, and B. F. de St. Groth
The Avidity Spectrum of T Cell Receptor Interactions Accounts for T Cell Anergy in a Double Transgenic Model
J. Exp. Med., January 18, 1999; 189(2): 265 - 278.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Zamauskaite, I. Perez-Cruz, M. Yaqoob, J. Madrigal, and S. Cohen
Effect of renal dialysis therapy modality on T cell cytokine production
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 49 - 55.
[Abstract] [PDF]


Home page
J. Immunol.Home page
C. B. Schmidt-Weber, S. I. Alexander, L. E. Henault, L. James, and A. H. Lichtman
IL-4 Enhances IL-10 Gene Expression in Murine Th2 Cells in the Absence of TCR Engagement
J. Immunol., January 1, 1999; 162(1): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Lauffenburger, G. T. Oehrtman, L. Walker, and H. S. Wiley
Real-time quantitative measurement of autocrine ligand binding indicates that autocrine loops are spatially localized
PNAS, December 22, 1998; 95(26): 15368 - 15373.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. W. Redford, A.-K. Yi, C. T. Ward, and A. M. Krieg
Cyclosporin A Enhances IL-12 Production by CpG Motifs in Bacterial DNA and Synthetic Oligodeoxynucleotides
J. Immunol., October 15, 1998; 161(8): 3930 - 3935.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.